Halozyme Therapeutics
HALO
Hutchmed (China)
HCM
Lantheus
LNTH
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Teradata Corp
TDC
US Stock MarketDetailed Quotes
ADAP Adaptimmune Therapeutics
- 0.650
- +0.001+0.14%
Close Jan 6 16:00 ET
- 0.680
- +0.030+4.60%
Post 20:01 ET
166.32MMarket Cap-3.89P/E (TTM)
0.685High0.645Low1.05MVolume0.649Open0.649Pre Close696.86KTurnover0.61%Turnover RatioLossP/E (Static)255.88MShares2.05052wk High2.08P/B113.01MFloat Cap0.53252wk Low--Dividend TTM173.86MShs Float21.570Historical High--Div YieldTTM6.16%Amplitude0.420Historical Low0.662Avg Price1Lot Size
Adaptimmune Therapeutics News
Adaptimmune Therapeutics | 8-K: Current report
Adaptimmune Therapeutics | SCHEDULE 13G/A: Others
Adaptimmune Therapeutics | 10-Q: Q3 2024 Earnings Report
Adaptimmune Therapeutics | 8-K: Current report
Adaptimmune Therapeutics | 8-K: Current report
Adaptimmune Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Matrix Capital Management Company LP(14.73%),David E. Goel(14.73%)
Adaptimmune Therapeutics | 8-K: Current report
Adaptimmune Therapeutics | 8-K: Current report
Adaptimmune Therapeutics | 10-Q: Q2 2024 Earnings Report
Adaptimmune Therapeutics | 8-K: Current report
Adaptimmune Therapeutics | 8-K: Current report
Adaptimmune Therapeutics | 8-K: Current report
Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Behbahani Ali
Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director MOTT DAVID M
Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Menzel Garry E
Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Alleva Lawrence M
Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Furey John
Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hegde Priti
Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hege Kristen
Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Allen Andrew R
